| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027841 |
| Receipt No. | R000027619 |
| Official scientific title of the study | Evaluarion of the usefulness of indocyanine green fluorescence imaging in pancreatic surgery. |
| Date of disclosure of the study information | 2017/06/21 |
| Last modified on | 2018/12/21 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Evaluarion of the usefulness of indocyanine green fluorescence imaging in pancreatic surgery. | |
| Title of the study (Brief title) | Fluorescence imaging for pancreatic surgery. | |
| Region |
|
|
| Condition | ||
| Condition | pancreatic cancer, cystic tumor in pancreas, neuroendocrine tumor, intrapapillary mucinous neoplasm, Solid pseudopapillary neoplasm | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the efficacy of indocyanine green fluorescence imaging for pancreatic surgery. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Primary outcome is to assess fluorescence pattern of pancreatic lesion. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Objictives:pancreatic cancer, pancreatic neuroendocrine tumor, intrapapillaly mucinous neoplasm, solid pseudopapillaly neoplasm
1)patient 20 years old or older. 2)patient who receive enough explanation, understand enough, and can agree with the study of their own accord. |
|||
| Key exclusion criteria | 1)there is an allergy carrer for indocyanine green.
2)there is an allergy carrer for iodine . 3)The patient who is judged to be inappropriate from medical grounds. |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Norihiro Kokudo |
| Organization | Graduate School of Medicine, University of Tokyo |
| Division name | Hepato-Biliary-Pancreatic Surgery Division |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan |
| TEL | +81338155411 |
| KOKUDO-2SU@h.u-tokyo.ac.jp | |
| Public contact | |
| Name of contact person | Chikara Shirata |
| Organization | Graduate School of Medicine, University of Tokyo |
| Division name | Hepato-Biliary-Pancreatic Surgery Division |
| Address | 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan |
| TEL | +81338155411 |
| Homepage URL | |
| shiratac-tky@umin.ac.jp | |
| Sponsor | |
| Institute | University of Tokyo |
| Institute | |
| Department | |
| Funding Source | |
| Organization | University of Tokyo |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | We evaluated the usefulness of fluorescence imaging using indocyanine green to identify pancreas tumors in 23 patients undergoing pancreas resection. This technique was useful in visualizing pancreas lesions during surgery, specifically, neuroendocrine tumors as fluorescence and cystic neoplasms as a fluorescence defect. |
| Other related information | not applicable |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000027619 |